Effect of Heat Shock on the Expression of Urokinase-Type Plasminogen Activator Receptor in Human Umbilical Vein Endothelial Cells

Summary

We investigated the effect of heat shock on the fibrinolytic potential of human umbilical vein endothelial cells (HUVECs) in culture. When cultured at 43° C, the mRNA for heat shock protein 70 (HSP70) was dramatically induced within 120 min with a maximal induction of more than 90-fold compared with that in HUVECs cultured at 37° C. The level of urokinase-type plasminogen activator (u-PA) receptor (u-PAR) mRNA increased up to 2.2-fold in response to heat shock, which was associated with the increased u-PA binding and cell-surface u-PA activity determined by adding exogenous u-PA to acid-treated HUVECs. The increased u-PAR mRNA returned to normal level when HUVECs were further incubated at 37° C for 180 min, and this decline was not affected in the presence of actinomycin D. Though the secreted antigens for tissue-type plasminogen activator (t-PA) and type 1 plasminogen activator inhibitor (PAI-1) in the conditioned medium (CM) of HUVECs were simultaneously increased at 43° C during this period, the increase in the levels of t-PA (about 26.6-fold at 120 min) was greater than that of PAI-1 (1.8-fold at 120 min). The fibrinolytic activity of CM obtained from HUVECs at 43° C was significantly enhanced up to 3-fold, indicating that heat shock induced hyperfibrinolytic states in HUVECs. The secretion of u-PA into CM was also enhanced by heat shock. These results suggested that human endothelial cells respond to hyperthermia by inducing HSP70 followed by hyperfibrinolytic states with the enhanced expression of u-PAR as well as that of t-PA and u-PA.

• References

• 1 Loskutoff DJ, Edgington TS. Synthesis of a fibrinolytic activator and inhibitor by endothelial cells. Proc Natl Acad Sci USA 1977; 74: 3903-3907
• 2 Schleef RR, Loskutoff DJ. Fibrinolytic system of vascular endothelial cells. Haemostasis 1988; 18: 328-341
• 3 Schleef RR, Bevilacqua MP, Sawdey M, Gimbrone Jr MA, Loskutoff DJ. Cytokine activation of vascular endothelium: Effects on tissue-type plasminogen activator and type 1 plasminogen activator inhibitor. J Biol Chem 1988; 263: 5797-5803
• 4 Emeis JJ, Kooistra TJ. Interleukin 1 and lipopolysaccharide induce an inhibitor of tissue-type plasminogen activator in vivo and in cultured endothelial cells. Exp Med 1986; 163: 1260-1266
• 5 Medina R, Socher SH, Han JH, Friedman PA. Interleukin 1, endotoxin or tumor necrosis factor/cathectin enhance the level of plasminogen activator inhibitor messenger RNA in bovine aortic endothelial cells. Thromb Res 1989; 54: 41-52
• 6 Martin NB, Jamieson A, Tuffin DP. The effect of interleukin-4 on tumor necrosis factor alpha induced expression of tissue factor and plasminogen activator inhibitor-1 in human umbilical vein endothelial cells. Thromb Haemost 1993; 70: 1037-1042
• 7 Niedbala ML, Picarella MS. Tumor necrosis factor induction of endothelial cells urokinase-type plasminogen activator mediated proteolysis of extracellular matrix and its antagonism by y-interferon. Blood 1992; 79: 678-687
• 8 Moscatelli D. High and low affinity binding sites for basic fibroblast growth factor on cultured cells: Absence of a role for low affinity binding in the stimulation of plasminogen activator production by bovine capillary endothelial cells. J Cell Physiol 1987; 131: 123-130
• 9 Konkle BA, Ginsburg D. The addition of endothelial cell growth factor and heparin to human umbilical vein endothelial cell cultures decreases plasminogen activator inhibitor-1 expression. J Clin Invest 1988; 82: 579-585
• 10 Konkle BA, Kollrons PR, Kelly MD. Heparin-binding growth factor-1 modulation of plasminogen activator inhibitor-1 expression: Interaction with cAMP and protein kinase C-mediated pathways. J Biol Chem 1990; 265: 21867-21873
• 11 Mawatari M, Okamura K, Matsuda T, Hamanaka R, Mizoguchi H, Higashi-no K, Kohno K, Kuwano M. Tumor necrosis factor and epidermal growth factor modulate migration of human microvascular endothelial cells and production of tissue-type plasminogen activator and its inhibitor. Exp Cell Res 1991; 192: 574-580
• 12 Slivka SR, Loskutoff DJ. Platelets stimulate endothelial cells to synthesize typel plasminogen activator inhibitor. Evaluation of the role of transforming growth factor b. Blood 1991 77. 1013-1019
• 13 Patridge CA, Gerritsen ME. Dexamethasone increases the release of three 44 kDa proteins immunologically related to plasminogen activator inhibitor-1 from human umbilical vein endothelial and rabbit coronary micro vessel endothelial cells. Thromb Res 1990; 57: 139-154
• 14 Fukao H, Ueshima S, Tanaka N, Okada K, Matsuo O. Suppression of plasminogen activator inhibitor-1 release by fibrin from human umbilical vein endothelial cells. Thromb Res 1990; 57 (suppl X) 11-20
• 15 Hanss M, Collen D. Secretion of tissue-type plasminogen activator and plasminogen activator inhibitor by cultured human endothelial cells: Modulation by thrombin, endotoxin, and histamine. J Lab Clin Med 1987; 109: 97-104
• 16 Sultan Y, Harris A, Strauch G, Venot A, De Lauture D. A dynamic test to investigate potential tissue plasminogen activator activity. J Lab Clin Med 1988; 111: 645-653
• 17 Thompson EA, Nelles L, Collen D. Effect of retinoic acid on the synthesis of tissue-type plasminogen activator and plasminogen activator inhibitor-1 in human endothelial cells. Eur J Biochem 1991; 201: 627-632
• 18 Etingin OR, Hajjar DP, Hajjar KA, Harpel PC, Nachman RL. Lipoprotein (a) regulates plasminogen activator inhibitor-1 expression in endothelial cells: A potential mechanism in thrombogenesis. J Biol Chem 1991; 266: 2459-2465
• 19 Santell L, Marotti K, Bartfeld NS, Baynham P, Levin EG. Disruption of microtubules inhibits the stimulation of tissue plasminogen activator expression and promotes plasminogen activator inhibitor type 1 expression in human endothelial cells. Exp Cell Res 1992; 201: 358-365
• 20 Shatos MA, Doherty JM, Orfeo T, Hoak JC, Collen D, Stump D. Modulation of the fibrinolytic response of cultured human vascular endothelium by extracellularly generated oxygen radicals. J Biol Chem 1992; 267: 597-601
• 21 Tremoli E, Camera M, Madema P, Sironi L, Prati L, Colli S, Piovella F, Bernini F, Corsini A, Mussoni L. Increased synthesis of plasminogen activator inhibitor-1 by cultured human endothelial cells exposed to native and modified LDLs: An LDL receptor-independent phenomenon. Arteriosclerosis Thromb 1993; 13: 338-346
• 22 Yamamoto C, Kaji T, Sakamoto M, Kozuka H. Cadmium stimulation of plasminogen activator inhibitor-1 release from human vascular endothelial cells in culture. Toxicol 1993; 83: 215-223
• 23 Bamathan ES, Kuo A, Kariko K, Rosenfeld L, Murray C, Behrendt N, Ronne E, Weuner D, Henkin J, Cines DB. Characterization of human endothelial cell urokinase-type plasminogen activator receptor protein and messenger RNA. Blood 1990; 76: 1795-1806
• 24 Kaufmann SHE, Schoel B, Embden JDAV, Koga T, Wand-Wurttenberger A, Munk ME, Steinhoff U. Heat-shock protein 60: Implications for pathogenesis of and protection against bacterial infections. Immunol Rev 1991; 121: 67-90
• 25 Bergonzelli GE, Kruithof KO. Induction of plasminogen activator inhibitor-1 biosynthesis by hyperthermia. J Cell Physiol 1991; 148: 306-313
• 26 Ketis NV, Lawler J, Hoover RL, Kamovsky MJ. Effects of heat shock on the expression of thrombospondin by endothelial cells in culture. J Cell Biol 1988; 106: 893-904
• 27 Wojta J, Holzer M, Hufnagl P, Christ G, Hoover RL, Binder BR. Hyperthermia stimulates plasminogen activator inhibitor type 1 expression in human umbilical vein endothelial cells in vitro. Am J Pathol 1991; 139: 911-919
• 28 Ang C, Dawes J. The effects of hyperthermia on human endothelial mono-layeres: Modulation of thrombotic potential and permeability. Blood Coagulation Fibrinolysis 1994; 5: 193-199
• 29 Deutsch DG, Mertz ET. Plasminogen: Purification from human plasma by affinity chromatography. Science 1970; 170: 1095-1096
• 30 Jaffe EA, Hoyer LW, Nachmann R. Synthesis of antihemophilic factor antigen by cultured human endothelial cells. J Clin Invest 1980; 52: 2757-2764
• 31 Matsuo O, Sakai T, Bando H, Okada K, Nakajima S, Takagi O, Izaki S. Plasminogen activator in bronchoalveolar fluid. Hemostasis 1986; 16: 43-50
• 32 Edelberg JM, Reilly CF, Pizzo SV. The inhibition of tissue type plasminogen activator by plasminogen activator inhibitor-1: The effects of fibrinogen, heparin, vitronectin, and lipoprotein (a). J Biol Chem 1991; 266: 7488-7493
• 33 Fukao H, Ueshima S, Okada K, Yamamoto K, Matsuo T, Matsuo O. Tissue-type plasminogen activator, type 1 plasminogen activator inhibitor and their complex in plasma with disseminated intravascular coagulation. Thromb Res 1992; 68: 57-65
• 34 Ellis V, Behrendt N, Dano K. Plasminogen activation by receptor-bound urokinase: A kinetic study with both cell-associated and isolated receptors. J Biol Chem 1991; 266: 12752-12758
• 35 Dano K, Behrendt N, Brunner N, Ellis V, Ploug M, Pyke C. The urokinase receptor: Proteinstructure and role in plasminogen activation and cancer invasion. Fibrinolysis 1994; 8: 189-203
• 36 Fukao H, Hagiya Y, Nonaka T, Okada K, Matsuo O. Analysis of binding protein for tissue-type plasminogen activator in human endothelial cells. Biochem Biophys Res Commun 1992; 187: 956-962
• 37 Cheng X-F, Back O, Nilsson TK, Nylander LundqvistE, Pohl G, Wallen P. Binding of tissue plasminogen activator to human endothelial cells: Importance of the B-chain as a ligand. Biochem J 1992; 287: 407-413
• 38 Hajjar KA, Jacovina AT, Chacko J. An endothelial cell receptor for plasminogen/tissue plasminogen activator: Identity with annexin II. J Biol Chem 1994; 269: 21191-21197
• 39 Bamathan ES, Kuo A, Rosenfeld L, Kariko K, Leski M, Robbiati F, Nolli ML, Henkin J, Cines DB. Interaction of single-chain urokinase-type plasminogen activator with human endothelial cells. J Biol Chem 1991; 265: 2865-2872